✦ LIBER ✦

Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril

✍ Scribed by L. Caprio; M. L. Rosa; A. Palma; C. Lirato; P. Caccese; M. Sestito; S. Lastoria; A. M. Cicatiello; F. Rengo

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 487 KB
Volume: 8
Category: Article
ISSN: 0920-3206
DOI: 10.1007/bf00877120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative effects of fosinopril and ni

Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: A double-blind study

✍ H. G. Kirpizidis; G. S. Papazachariou 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 336 KB

Regression of cardiac hypertrophy in hyp

Regression of cardiac hypertrophy in hypertensive patients—comparison of Abana with propranolol

✍ Radha Yegnanarayan; S. A. Sangle; S. S. Sirsikar; D. K. Mitra 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

The effect of Abana and propranolol on left ventricular hypertrophy in hypertensive individuals was studied by echocardiography. The study showed an improvement in cardiac function as indicated by an increase in ejection fraction and fractional shortening in both the Abana-and propranolol-treated gr

Association of interleukin-6 -174G/C pro

Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients

✍ Losito, Attilio; Kalidas, Kamini; Santoni, Stefania; Jeffery, Steve 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

## Background: Gene polymorphisms of proinflammatory cytokines, such as interleukin-6 (il-6) and the chemokine receptor cx3cr1, have been found in association with cardiovascular disease in the general population. in dialysis patients, in whom the prevalence of cardiovascular comorbidity is strikin

Ventricular arrhythmias and echocardiogr

Ventricular arrhythmias and echocardiographic parameters of the left ventricular morphology in elderly patients with arterial hypertension

✍ K. Kawecka-Jaszcz; J. P. Dubiel; M. Skoczeń; D. Czarnecka; J. Kocemba; T. Grodzi 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 145 KB

Regression of left ventricular hypertrop

Regression of left ventricular hypertrophy in “Previously untreated” hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy

✍ Elyse Foster; Jonathan F. Plehn; Sheilah A. Bernard; Nancy J. Battinelli; Mary H 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 514 KB

In 10 hypertensive black patients who were "previously untreated" (defined as no antihypertensive therapy for a minimum of 12 months prior to enrollment) and who had LVH (defined by an increase in both wall thickness and echocardiographically determined LV mass), we studied the effects of treatment

Hemodynamic effects of iodixanol and ioh

Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function

✍ Arend Bergstra; René B. van Dijk; Oddmund Brekke; Arie E. Buurma; Leandro Orozco 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

A crossover study was performed to compare the hemodynamic effects of the isoosmolar contrast agent iodixanol (Visipaqueா) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaqueா) 350 mg I/ml. The main hypothesis was that iodixanol and iohexol would affect left ventricular end-diastolic pressure